Revamedical
1 known investors
REVA Medical develops and sells bioresorbable polymer-based implantable medical devices for vascular applications, including the MOTIV bioresorbable scaffold for below-the-knee peripheral artery disease, TyroSphere embolic microspheres for hypervascular tumors, and the Fantom Encore coronary bioresorbable scaffold. Its products use a proprietary polymer called Tyrocore and serve interventional vascular medicine.